32 /100
MEDIUM RISK
Score updated Jul 13, 2026

PRCT — PROCEPT BioRobotics Corporation Dilution Risk Tracker

Track PRCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRCT — Get alerts when the score changes →

As of July 13, 2026, PROCEPT BioRobotics Corporation (PRCT) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. PROCEPT BioRobotics Corporation has a market capitalization of $1.50B, 56.92M shares outstanding, 259 institutional holders tracked. Key dilution vectors include approximately 24 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
25
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PRCT.
🔔 Track PRCT — Get forecast alerts →

💹 Market Data

Market Cap$1.50B
Shares Outstanding56.92M
Float55.59M
Cash$245.64M
Debt$51.66M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.3% shares (2026Q1 vs prior)
259 institutional holders · 63.51M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.80M shares
#2 BlackRock, Inc. 4.36M shares
#3 T. Rowe Price Investment Management, Inc. 3.27M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.65M
Days to Cover3.9
% of Float13.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PRCT Shareholders

PROCEPT BioRobotics Corporation (PRCT) has a DilutionScore of 32/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for PRCT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for PRCT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PRCT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track PRCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PRCT
📊 PRCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PRCT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.